ESMO 2026: Analysts warm to Merck, Moderna’s cancer vaccine after frustrating data leak
With Merck and Moderna days removed from a data leak and the conference presentation in the rearview, analysts have softened…
With Merck and Moderna days removed from a data leak and the conference presentation in the rearview, analysts have softened…